Sientra reports growing revenue, shrinking losses in Q1
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra reports rising revenue, declining losses
Goleta-based Sientra reported record revenue for the fourth quarter and full year of 2021, and while the company still saw net losses, they were lower, the company reported March 23. Sientra, a breast implant manufacturer, had revenue of $22.6 million for the quarter, representing growth of 26.6% year-over-year, excluding discontinued operations. For the full year, Read More →
Sientra shares up after company releases 2021 revenue estimates
The Goleta-based breast implant manufacturer Sientra expects growth in the fourth quarter of 2021 and estimates its “highest-ever breast products yearly revenue” of up to $81 million for the full year, the company said Jan. 10. Sientra reported that its preliminary unaudited revenue from operations for the fourth quarter of 2021 is expected to be Read More →
Sientra misses earnings expectations but shares still gain after Q3 report
Goleta-based Sientra missed analysts’ expectations when it released financial results for the third quarter of 2021 on Nov. 10, posting a net loss when accounting for certain one-time factors such as the relief of its paycheck protection program loan. Sientra, a plastic surgery device company specializing in breast implants, had net income of $28.4 million Read More →
Sientra reports smaller loss for Q2
Sientra recorded a net loss in its most recent quarter, missing investor expectations, even as the company’s financials improved, according to financial results released Aug. 10. The Goleta-based breast implant manufacturer reported an $18.5 million loss from continuing operations in the second quarter, or 32 cents per share. The loss was a 40.7% decrease from Read More →
Sientra closes sale of miraDry at $10M loss
Sientra, a Goleta-based plastic surgery device company specializing in breast implants, announced June 11 that it had closed the sale of miraDry, a non-surgical dermatological treatment. The $10 million sale brought half of what Sientra paid for the business four years ago. The miraDry system is an FDA-approved treatment to reduce underarm sweat, hair and Read More →
Sales and losses both rise at Sientra
Sientra missed estimates and almost doubled its net loss over the course of a year, but saw increases in net sales and gross profit as well as decreases in operating expenses, according to its first-quarter earnings report, released May 11. The Goleta-based medical aesthetics company saw a net loss of $54.7 million, or $1.01 per Read More →
